Cargando…
Targeting RTK Signaling Pathways in Cancer
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation, differentiation and survival. The induction of these pathways depends on Receptor Tyrosine Kinases (RTKs) that are activated upon ligand binding. In cancer, constitutive and aberrant activations of c...
Autor principal: | Regad, Tarik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586793/ https://www.ncbi.nlm.nih.gov/pubmed/26404379 http://dx.doi.org/10.3390/cancers7030860 |
Ejemplares similares
-
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
por: Gong, Ke, et al.
Publicado: (2021) -
Targeting cellular pathways in glioblastoma multiforme
por: Pearson, Joshua R D, et al.
Publicado: (2017) -
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
por: Yang, Hsin-Han, et al.
Publicado: (2021) -
The trigger (and the restriction) of Torso RTK activation
por: Mineo, Alessandro, et al.
Publicado: (2018) -
Cancer Stem Cells and Targeting Strategies
por: Barbato, Luisa, et al.
Publicado: (2019)